Výsledky vyhledávání

Myeloproliferative disorder with eosinophilia and ETV6-ABL gene rearrangement: efficacy of second-generation tyrosine kinase inhibitors

Autor: Ajit Divgi, Christopher Bredeson, Steven H. Kroft, Ehab Atallah, Christine R. Bryke, Ranveer Nand

Publikováno v: Leukemia research. 33(8)

ETV6/ABL is a rare gene rearrangement that has rarely been detected in Philadelphia-negative chronic myeloproliferative disorders (C-MPD) and found to have tyrosine kinase activity similar to the BCR/ABL fusion protein. We describe a case of a 61-yea

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf3c4b532049344720d70d4ccf0570f4
https://pubmed.ncbi.nlm.nih.gov/19394693

Zobrazit plný text záznamu

Myeloid sarcoma presenting as an isolated nodule in a patient with acute myelogenous leukemia

Autor: Neal, Bhatia, Timothy, Wallace, Ajit, Divgi, Vicky, Short

Publikováno v: Journal of drugs in dermatology : JDD. 6(4)

We report a case of an elderly female in remission from acute myelogenous leukemia that presented with a nonhealing enlarging asymptomatic nodule on her right thigh. A wide excision of the nodule and histological examination revealed myeloid sarcoma

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::9e44be93d8fd36ad3f7e29cdbca25c87
https://pubmed.ncbi.nlm.nih.gov/17668545

Zobrazit plný text záznamu

Thrombocytopenia after second exposure to abciximab is caused by antibodies that recognize abciximab-coated platelets

Autor: Julia Swyers, Brian R. Curtis, Richard H. Aster, Janice G. McFarland, Ajit Divgi

Publikováno v: Blood. 99(6)

Thrombocytopenia, often severe, occurs in 1% to 2% of patients given the fibrinogen receptor antagonist abciximab, a chimeric Fab fragment containing murine specificity-determining and human framework sequences. The cause of this complication has not

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8dbd77f401abbe2e02df23f6b5969d43
https://pubmed.ncbi.nlm.nih.gov/11877279

Zobrazit plný text záznamu

Pentoxifylline, ciprofloxacin and dexamethasone improve the ineffective hematopoiesis in myelodysplastic syndrome patients

Autor: Saleem Dar, Jerome Loew, Stephanie A. Gregory, Tanja Andric, Azra Raza, Ajit Divgi, Laurie Lisak, Raywin Huang, Parameswaran Venugopal, Wei-Tong Hsu, Robert Taylor, E. Robin, S. Rifkin, Alan Grosset, Huma Qawi, Sefer Gezer, R. Shah

Publikováno v: Scopus-Elsevier

Twenty-five patients with a diagnosis of myelodysplastic syndromes (MDS) were randomized to either begin therapy with pentoxifylline, ciprofloxacin and dexamethasone (PCD) immediately (10 patients) or after a 12 week observation period (control arm,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20c8c4de5c1eb9e9e5b5f2df1f91e8fc
http://www.scopus.com/inward/record.url?eid=2-s2.0-0034468435&partnerID=MN8TOARS

Zobrazit plný text záznamu

Clinical Notes

Autor: Brian P. Buggy, Ajit Divgi

Publikováno v: American Pharmacy. 25:4

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7e1c6a3b2156a76696da5a551abdc5ec
https://doi.org/10.1016/s0160-3450(16)32570-3

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání